These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 16799160)

  • 21. Reduction of postoperative spinal implant infection using gentamicin microspheres.
    Stall AC; Becker E; Ludwig SC; Gelb D; Poelstra KA
    Spine (Phila Pa 1976); 2009 Mar; 34(5):479-83. PubMed ID: 19247168
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The release of cefazolin and gentamicin from biodegradable PLA/PGA beads.
    Wang G; Liu SJ; Ueng SW; Chan EC
    Int J Pharm; 2004 Apr; 273(1-2):203-12. PubMed ID: 15010144
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nanostructured microspheres produced by supercritical fluid extraction of emulsions.
    Della Porta G; Reverchon E
    Biotechnol Bioeng; 2008 Aug; 100(5):1020-33. PubMed ID: 18383122
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Determination of gentamicin in different matrices by a new sensitive high-performance liquid chromatography-mass spectrometric method.
    Lecároz C; Campanero MA; Gamazo C; Blanco-Prieto MJ
    J Antimicrob Chemother; 2006 Sep; 58(3):557-63. PubMed ID: 16787953
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nano/micro technologies for delivering macromolecular therapeutics using poly(D,L-lactide-co-glycolide) and its derivatives.
    Mundargi RC; Babu VR; Rangaswamy V; Patel P; Aminabhavi TM
    J Control Release; 2008 Feb; 125(3):193-209. PubMed ID: 18083265
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of lactide/glycolide ratio on the in vitro release of ganciclovir and its lipophilic prodrug (GCV-monobutyrate) from PLGA microspheres.
    Janoria KG; Mitra AK
    Int J Pharm; 2007 Jun; 338(1-2):133-41. PubMed ID: 17363204
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influence of microencapsulation method and peptide loading on formulation of poly(lactide-co-glycolide) insulin nanoparticles.
    Kumar PS; Ramakrishna S; Saini TR; Diwan PV
    Pharmazie; 2006 Jul; 61(7):613-7. PubMed ID: 16889069
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nafcillin-loaded PLGA nanoparticles for treatment of osteomyelitis.
    Pillai RR; Somayaji SN; Rabinovich M; Hudson MC; Gonsalves KE
    Biomed Mater; 2008 Sep; 3(3):034114. PubMed ID: 18708713
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Optimum conditions for efficient phagocytosis of rifampicin-loaded PLGA microspheres by alveolar macrophages.
    Hirota K; Hasegawa T; Hinata H; Ito F; Inagawa H; Kochi C; Soma G; Makino K; Terada H
    J Control Release; 2007 May; 119(1):69-76. PubMed ID: 17335927
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Targeting Brucella melitensis with polymeric nanoparticles containing streptomycin and doxycycline.
    Seleem MN; Jain N; Pothayee N; Ranjan A; Riffle JS; Sriranganathan N
    FEMS Microbiol Lett; 2009 May; 294(1):24-31. PubMed ID: 19493005
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy of amoxicillin bearing microsphere formulation in treatment of Listeria monocytogenes infection in Swiss albino mice.
    Farazuddin M; Alam M; Khan AA; Khan N; Parvez S; Dutt GU; Mohammad O
    J Drug Target; 2010 Jan; 18(1):45-52. PubMed ID: 19624287
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Controlled release of gentamicin from calcium phosphate-poly(lactic acid-co-glycolic acid) composite bone cement.
    Schnieders J; Gbureck U; Thull R; Kissel T
    Biomaterials; 2006 Aug; 27(23):4239-49. PubMed ID: 16620958
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preparation and antibacterial activity evaluation of rifampicin-loaded poly lactide-co-glycolide nanoparticles.
    Esmaeili F; Hosseini-Nasr M; Rad-Malekshahi M; Samadi N; Atyabi F; Dinarvand R
    Nanomedicine; 2007 Jun; 3(2):161-7. PubMed ID: 17468055
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of process and formulation parameters on characteristics and internal morphology of poly(d,l-lactide-co-glycolide) microspheres formed by the solvent evaporation method.
    Mao S; Shi Y; Li L; Xu J; Schaper A; Kissel T
    Eur J Pharm Biopharm; 2008 Feb; 68(2):214-23. PubMed ID: 17651954
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Release mechanisms from gentamicin loaded poly(lactic-co-glycolic acid) (PLGA) microparticles.
    Friess W; Schlapp M
    J Pharm Sci; 2002 Mar; 91(3):845-55. PubMed ID: 11920769
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A novel trans-lymphatic drug delivery system: implantable gelatin sponge impregnated with PLGA-paclitaxel microspheres.
    Liu J; Meisner D; Kwong E; Wu XY; Johnston MR
    Biomaterials; 2007 Jul; 28(21):3236-44. PubMed ID: 17434581
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of lung surfactants on rifampicin release rate from monodisperse rifampicin-loaded PLGA microspheres.
    Tomoda K; Makino K
    Colloids Surf B Biointerfaces; 2007 Mar; 55(1):115-24. PubMed ID: 17197161
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A protein/antibiotic releasing poly(lactic-co-glycolic acid)/lecithin scaffold for bone repair applications.
    Shi X; Wang Y; Ren L; Huang W; Wang DA
    Int J Pharm; 2009 May; 373(1-2):85-92. PubMed ID: 19429292
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Polyelectrolyte complex of chondroitin sulfate and peptide with lower pI value in poly(lactide-co-glycolide) microsphere for stability and controlled release.
    Park W; Na K
    Colloids Surf B Biointerfaces; 2009 Sep; 72(2):193-200. PubMed ID: 19414243
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fabrication and characterization of PLGA/HAp composite scaffolds for delivery of BMP-2 plasmid DNA.
    Nie H; Wang CH
    J Control Release; 2007 Jul; 120(1-2):111-21. PubMed ID: 17512077
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.